/ /

  • linkedin
  • Increase Font
  • Sharebar

    Innovation in glaucoma thriving

    New drugs, devices, diagnostics ‘nicely’ fueling growth



    The latest development in diagnostics is devices for continuous monitoring. Two competing designs are moving through development.

    Sensimed’s Triggerfish is an external device that provides continuous IOP measurement. Implandata Ophthalmic Products is developing a permanent device to be implanted during cataract surgery. IOP data are transmitted to an external unit, using an RFID-powered system originally used in automotive applications.

    “These are both promising products, given that more data is always better,” Dr. Cunningham said. “The major unanswered question is who will pay for such data, and whether outcomes data will need to be generated to convince payers.”

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results